Alaunos Therapeutics Inc (TCRT)
2.03
-0.01
(-0.49%)
USD |
NASDAQ |
Nov 04, 12:57
Alaunos Therapeutics Total Liabilities (Quarterly): 0.907M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 0.907M |
March 31, 2024 | 1.24M |
December 31, 2023 | 1.956M |
September 30, 2023 | 5.54M |
June 30, 2023 | 6.277M |
March 31, 2023 | 19.13M |
December 31, 2022 | 26.38M |
September 30, 2022 | 35.23M |
June 30, 2022 | 33.75M |
March 31, 2022 | 35.87M |
December 31, 2021 | 36.81M |
September 30, 2021 | 45.06M |
June 30, 2021 | 18.48M |
March 31, 2021 | 22.83M |
December 31, 2020 | 22.36M |
September 30, 2020 | 20.98M |
June 30, 2020 | 18.26M |
March 31, 2020 | 17.94M |
December 31, 2019 | 14.10M |
September 30, 2019 | 11.82M |
June 30, 2019 | 11.18M |
March 31, 2019 | 9.287M |
December 31, 2018 | 9.487M |
September 30, 2018 | 62.79M |
June 30, 2018 | 61.19M |
Date | Value |
---|---|
March 31, 2018 | 61.57M |
December 31, 2017 | 58.42M |
September 30, 2017 | 57.29M |
June 30, 2017 | 56.85M |
March 31, 2017 | 59.96M |
December 31, 2016 | 58.32M |
September 30, 2016 | 59.73M |
June 30, 2016 | 180.00M |
March 31, 2016 | 63.87M |
December 31, 2015 | 66.35M |
September 30, 2015 | 79.52M |
June 30, 2015 | 13.60M |
March 31, 2015 | 11.04M |
December 31, 2014 | 11.40M |
September 30, 2014 | 12.63M |
June 30, 2014 | 17.63M |
March 31, 2014 | 21.59M |
December 31, 2013 | 22.37M |
September 30, 2013 | 25.85M |
June 30, 2013 | 26.27M |
March 31, 2013 | 25.45M |
December 31, 2012 | 34.96M |
September 30, 2012 | 46.61M |
June 30, 2012 | 46.74M |
March 31, 2012 | 43.17M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.907M
Minimum
Jun 2024
45.06M
Maximum
Sep 2021
20.16M
Average
19.13M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
Perspective Therapeutics Inc | 44.92M |
Oragenics Inc | 1.383M |
Cocrystal Pharma Inc | 4.183M |
Cara Therapeutics Inc | 60.90M |
Jaguar Health Inc | 44.88M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 4.678M |
Shareholders Equity (Quarterly) | 3.771M |
Current Ratio | 5.158 |
Net Debt Paydown Yield | 19.63% |